Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based

A J Brent1, I Ahmed, M Ndiritu

  • 1Wellcome Trust/KEMRI Centre for Geographic Medicine Research, Coast, PO Box 230, Kilifi, Kenya. andrew_brent@doctors.org.uk

Lancet (London, England)
|February 14, 2006
PubMed

Insights

Invasive bacterial disease, including pneumococcal bacteraemia, is twice as common in Kenyan children as previously thought. These findings support the urgent need for pneumococcal vaccine implementation in sub-Saharan Africa.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Invasive bacterial disease (IBD) burden estimates in sub-Saharan Africa often underestimate the true incidence by focusing only on hospitalized patients.
  • Underestimation of IBD incidence hampers effective vaccine implementation strategies in the region.
  • This study aimed to determine the incidence of bacteraemia in all children presenting to a Kenyan hospital, regardless of their clinical condition or admission status.

Purpose of the Study:

  • To accurately assess the incidence of bacteraemia in children presenting to a hospital in Kenya.
  • To evaluate the clinical significance of bacteraemia and the effectiveness of clinical signs in its diagnosis.
  • To provide data supporting public health interventions, such as vaccine introduction.

Main Methods:

  • A community-based observational study involving blood cultures from 1093 children attending a Kenyan hospital's outpatient department.
  • Utilized a Demographic Surveillance System to estimate bacteraemia incidence.
  • Investigated the clinical presentation, outcomes, and diagnostic utility of clinical signs for bacteraemia.

Main Results:

  • The overall yearly incidence of bacteraemia was 2440 per 100,000 children under 2 years and 1192 per 100,000 children under 5 years.
  • Pneumococcal bacteraemia incidence was 597 per 100,000 children under 5 years.
  • Clinically significant bacteraemia was twice as common, and pneumococcal bacteraemia four times as common, as previously estimated, with clinical signs proving poor indicators.

Conclusions:

  • Clinically significant bacteraemia is more prevalent in Kenyan children than previously reported.
  • The high incidence of pneumococcal bacteraemia strongly supports the introduction and widespread use of the pneumococcal vaccine in sub-Saharan Africa.
  • Accurate incidence data are crucial for effective disease control and prevention programs.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...